Cell-Line Development CDMOs
63 published
63 published CDMOs match Cell-Line Development.
Locations in this set include United States, United Kingdom, China, Germany, India, and Japan.
Capabilities that show up most often in this set: Biologics (Other), Biologics (Monoclonal Antibodies), Gene Therapy, Cell Therapy, and AAV / Viral Vector Platform.
Matching companies
WuXi BiologicsGlobal biologic CDMO offering end-to-end solutions from discovery to commercialization.
WuXi VaccinesGlobal CDMO specializing in end-to-end vaccine and prophylactic antibody development and manufacturing across mammalian, viral, and microbial platforms with GMP-certified facilities and over 550 million doses delivered.
Yapan BioYapan Bio provides integrated process development, characterization, and GMP manufacturing for vaccines, monoclonal antibodies, gene therapy, and viral vector-based biologics, with capabilities up to 1000L bioreactor scale and BSL-2+ containment.
Markdown mirror: /services/cell-line-development.md